Conferences
ESMO 2023: ICECaP-2: Validation of Metastasis-Free Survival as a Surrogate for Overall Survival in Localized Prostate Cancer in a More Contemporary Era
October 21, 2023
ESMO 2023: Invited Discussant: ICRA Trial & The Double Antibody Drug Conjugate (DAD) Trial
October 21, 2023
ESMO 2023: HRD Complete, a Novel Next Generation Sequencing Assay for Detecting Homologous Recombination Repair Gene Alterations in Prostate Cancer
October 21, 2023
ESMO 2023: Invited Discussant: Phase 3 THOR Study & THOR-2 Cohort 1
October 21, 2023
ESMO 2023: Association of Health-Related Quality of Life with Efficacy Outcomes in the VISION Study of Patients with mCRPC
October 21, 2023
ESMO 2023: ARASTEP: Darolutamide + ADT in Patients with High-Risk BCR Prostate Cancer – A Phase 3 Study
October 21, 2023
ESMO 2023: New Therapeutic Targets in Advanced Renal Cell Carcinoma (RCC) and Data from Sequencing Trials
October 20, 2023
ESMO 2023: What is the Role of Localized Therapies in Metastatic Renal Cell Carcinoma (RCC)?
October 20, 2023
ESMO 2023: Invited Discussant: Is More Always Better?
October 20, 2023